Related Experiment Video
Updated: Jun 6, 2026

07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
EPIC: multi-objective guided diffusion for epitope design in TCR-pMHC complexes
Yueshan Huang1, Gufeng Yu1, Letian Chen1,2
1AGI Institute, School of Computer Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Bioinformatics (Oxford, England)
|June 4, 2026
Summary
EPIC is a novel computational framework for designing novel epitopes that bind to T cell receptors (TCRs) and peptide-MHC (pMHC) complexes. This tool enables the creation of personalized cancer vaccines and therapies by optimizing antigenicity, MHC presentation, and TCR specificity.
Area of Science:
- Computational biology
- Immunology
- Bioinformatics
Background:
- T cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes is crucial for adaptive immunity.
- Designing immunogenic epitopes is challenging due to complex binding constraints and limited data.
- Existing methods cannot simultaneously ensure antigenicity, MHC presentation, and TCR specificity.
Purpose of the Study:
- To develop a computational framework for the de novo design of epitopes.
- To address the limitations of existing epitope design methods by integrating triplet binding constraints.
- To enable the generation of epitopes with tailored immunological properties.
Main Methods:
- EPIC utilizes a multi-objective diffusion framework.
- It decomposes TCR-pMHC binding into three biologically grounded sub-tasks.
- ESM-based classifiers and a peptide diffusion generator are integrated, leveraging diverse immunological datasets.
Main Results:
- EPIC-designed epitopes show improved predicted interface energies compared to ground-truth epitopes.
- Generated epitopes demonstrate high sequence novelty (80.1%), uniqueness (100%), and diversity (64.05%).
- The framework achieves high antigenicity scores (0.4723) and comparable structural confidence.
Conclusions:
- EPIC is the first computational framework for de novo epitope design integrating TCR-pMHC triplet constraints.
- This approach facilitates the design of epitopes for personalized cancer vaccines and T cell therapies.
- EPIC represents a paradigm shift from epitope discovery to rational epitope design.

